leukaemia
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
leukaemia
Apr 15, 2024, 04:04 |
Blog
Amalya Sargsyan: Proud to see IMMONC spotlighted in ASCO's latest policy statement on global equity in clinical trials
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, posted on LinkedIn: "Extremely proud to…
Mar 5, 2024, 15:38 |
Insight
Australian researchers are looking to nanotechnology for a new approach to treating children with cancer - Children's Cancer Institute
Children's Cancer Institute shared a post on LinkedIn: "Australian researchers are looking to nanotechnology for…
Sep 28, 2023, 18:16 |
Blog
We're proud to have partnered with Harley Staples to fund new research into why leukaemia relapses. - Children’s Cancer and Leukaemia Group
Children’s Cancer and Leukaemia Group shared on their X/Twitter page: ''We're proud to have partnered…
Aug 17, 2023, 05:16 |
Blog
Yesterday we welcomed our little one from South America, Guyana - Pediatric Cancer and Blood Disorders Center of Armenia
Pediatric Cancer and Blood Disorders Center of Armenia shared on their LinkedIn page: ''Yesterday we…
Aug 2, 2023, 19:13 |
Blog
Today marks the opening for applications to The Leukemia and Lymphoma Society Scholarship for Blood Cancer Survivors for the 2024-25 academic year - Ulrike Szalay
Today marks the opening for applications to The Leukemia and Lymphoma Society Scholarship for Blood Cancer…
Jul 7, 2023, 09:17 |
Opinion
We've funded 2 research projects into childhood acute lymphoblastic leukaemia (ALL) thanks to our Special Named Funds - Children’s Cancer and Leukaemia Group
We've funded 2 research projects into childhood acute lymphoblastic leukaemia (ALL) thanks to our Special…
All:
6
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube